SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-017532
Filing Date
2024-01-29
Accepted
2024-01-29 08:46:51
Documents
4
Period of Report
2024-02-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d575366ddef14a.htm DEF 14A 2392743
2 GRAPHIC g575366g17d02.jpg GRAPHIC 75548
3 GRAPHIC g575366g23z17.jpg GRAPHIC 32308
4 GRAPHIC g575366g58g58.jpg GRAPHIC 88106
  Complete submission text file 0001193125-24-017532.txt   2654855
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38130 | Film No.: 24570561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)